GBT TECHNOLOGIES INC.

GTCH

CIK 0001471781 · Quarterly mode · latest period FY2023 (Q2) (ending 2023-06-30) · sourced from SEC EDGAR

At a glance · FY2023 (Q2)

Revenue
$131K
↓-61.9% -$214Kvs FY2022 (Q2)
Gross Profit
$0
↓-100.0% -$166Kvs FY2022 (Q2)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
0/100
  • Profitability
    0ROIC 2.6% (10% = solid, 20%+ = moat)
  • Liquidity
    0Current Ratio 0.00 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.00x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -61.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project GTCH's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$0.00
Total enterprise IV
$8K
Diluted shares
653.86B
Terminal PV
$6K (72% of total)
Year-5 FCF
$691
YearProjected FCFDiscounted PV
+1$508$461
+2$548$453
+3$592$445
+4$639$437
+5$691$429
Terminal$9K$6K

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$603
everything owned
Total liabilities
$11M
everything owed
Stockholders' equity
$-10M
shareholder claim

Recent performance · 62 quarters

Revenue↓-61.9% -$214K
$131K
Net Income↓-102.9% -$6M
$-180K
Free Cash Flow↓-96.4% -$22K
$813
Operating Margin↓-10.7pts
-231.3%

Drill down